Position in BIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$469,415
-$2,511,691 QoQ
Shares Held
1,684
-84.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $192,927,826 across 18 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
482,525 | $37,747,930 | |
| 2 | GMED |
Globus Medical Inc
|
351,974 | $27,809,465 | |
| 3 | DXCM |
Dexcom Inc
|
400,929 | $27,002,568 | |
| 4 | EW |
Edwards Lifesciences Corp
|
275,279 | $24,901,738 | |
| 5 | PODD |
Insulet Corp
|
156,413 | $23,813,879 | |
| 6 | BSX |
Boston Scientific Corp
|
442,036 | $18,866,096 | |
| 7 | SNN |
Smith & Nephew PLC
|
263,854 | $7,601,633 | |
| 8 | ABT |
Abbott Laboratories
|
59,775 | $5,423,983 |
All Filings in BIO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $469,415 | 1,684 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $2,981,106 | 10,632 | Shares | Sole | 2025-11-13 | |
| 2023-12-31 | $248,948 | 771 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,007,263 | 16,759 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,243,727 | 16,469 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $384,653 | 803 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,034,947 | 11,974 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,508,564 | 8,411 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,600,335 | 3,233 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $216,843 | 385 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||